Chen Y-CI, Galpern W, Brownell A-L, Matthews RT, Bogdanov M,
Isacson O, Keltner JR, Beal MF, Rosen B, Jenkins BG. 1997. De- tection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis and behavioral data.
Magn Reson Med 38:389 –398.
Chen Y-CI, Brownell A-L, Galpern W, Isacson O, Bogdanov M, Beal
MF, Livni E, Rosen BR, Jenkins BG. 1999. Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI,
PET and behavioural assessment. NeuroReport 10:2881–2886.
Choi J, Chen Y-CI, Hamel E, Jenkins BG. 2003. Coupling of hemodynamic changes induced by dopamine drugs with dopamine receptor
distribution on the cerebral microvasculature. In: Book of abstracts:
11th Annual Meeting of the International Society of Magnetic Resonance in Medicine. p 356.
Cox RW, Hyde JS. 1997. Software tools for analysis and visualization
of FMRI Data. NMR Biomed 10:171–178.
Di Ciano P, Underwood RJ, Hagan JJ, Everitt BJ. 2003. Attenuation
of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28:329 –
338.
Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P.
2000. Dopamine D3 receptors expressed by all mesencephalic do- pamine neurons. J Neurosci 20:8677– 8684.
Floresco SB, Todd CL, Grace AA. 2001. Glutamatergic afferents from
the hippocampus to the nucleus accumbens regulate activity of
ventral tegmental area dopamine neurons. J Neurosci 21:4915–
4922.
Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. 1996. In
vivo evidence for preferential role of dopamine D3 receptor in the
presynaptic regulation of dopamine release but not synthesis. Eur
J Pharmacol 308:261–269.
Genovese CR, Lazar NA, Nichols T. 2002. Thresholding of statistical
maps in functional neuroimaging using the false discovery rate.
NeuroImage 15:870 – 878.
Groenewegen HJ, Vermeulen-Van der Zee E, te KA, Witter MP. 1987.
Organization of the projections from the subiculum to the ventral
striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 23:103–120.
Gurevich EV, Joyce JN. 1999. Distribution of dopamine D3 receptor
expressing neurons in the human forebrain: comparison with D2
receptor expressing neurons. Neuropsychopharmacology 20:60 – 80.
Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B,
James MF, Huang CL-H. 2001. Mapping of brain activation in
response to pharmacological agents using fMRI in the rat. Magn
Reson Imag 19:905–919.
Jaworski JN, Gonzales RA, Randall PK. 2001. Effect of dopamine
D2/D3 receptor antagonist sulpiride on amphetamine-induced
changes in striatal extracellular dopamine. Eur J Pharmacol 418:
201–206.
Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov
RR, Caron MG, Wightman RM. 2002. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of
D(3) receptors. Neuroscience 112:39 – 49.
Kalivas PW, McFarland K. 2003. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168:
44 –56.
Koob GF. 2003. Neuroadaptive mechanisms of addiction: studies on
the extended amygdala. Eur Neuropsychopharmacol 13:442– 452.
Lacroix LP, Hows ME, Shah AJ, Hagan JJ, Heidbreder CA. 2003.
Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology 28:839 – 849.
Landwehrmeyer B, Mengod G, Palacios JM. 1993. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A
comparative study using in situ hybridization histochemistry and
ligand binding autoradiography. Eur J Neurosci 5:145–153.
Le AD, Tomkins D, Higgins G, Quan B, Sellers EM. 1997. Effects of
5-HT3, D1 and D2 receptor antagonists on ethanol- and cocaineinduced locomotion. Pharmacol Biochem Behav 57:325–332.
Lejeune F, Millan MJ. 1995. Activation of dopamine D3 autoreceptors
inhibits firing of ventral tegmental dopaminergic neurones in vivo.
Eur J Pharmacol 275:R7–R9.
Levesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D,
Morgat JL, Schwartz JC, Sokoloff P. 1992. Identification, characterization, and localization of the dopamine D3 receptor in rat brain
using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl
Acad Sci U S A 89:8155– 8159.
Lowe AS, Williams SCR, Symms MR, Stolerman IP, Shoaib M. 2002.
Functional magnetic resonance neuroimaging of drug dependence:
